Heterobifunctional compounds for selectin inhibition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090036386A1
SERIAL NO

11920499

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise glycomimetics linked to a compound, for example a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids) or a member of a class of compounds termed BACAs (Benzyl Amino Carboxylic Acids).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLYCOMIMETICS INC9708 MEDICAL CENTER DR ROCKVILLE MD 20850

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Magnani, John L Gaithersburg, US 95 1078
Patton,, JR John T Gaithersburg , US 12 245
Sarkar, Arun K North Potomac, US 40 462

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation